EDGAR Filing Documents for 0000947871-13-000727

Form 13F-NT - Quarterly report filed by institutional managers, Notice:

SEC Accession No. 0000947871-13-000727

Filing Date

2013-10-31

Accepted

2013-10-31 09:26:03

Documents

Period of Report

2013-09-30

Effectiveness Date

2013-10-31

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	13F-NT
1		primary_doc.xml	13F-NT	2170
	Complete submission text file	0000947871-13-000727.txt		3210

Mailing Address FREISCHUETZGASSE 3 ZURICH V8 8004

Business Address FREISCHUETZGASSE 3 ZURICH V8 8004 41-61-275-9200

Adamant Biomedical Investments AG (Filer) CIK: 0001542336 (see all company filings)